Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
6,055.00    30.00 (0.50%)
Bid:
6,055.00
Ask:
6,060.00
Spread: 5.00 (0.083%)
Market Cap: £5.17b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Board Changes

16 Jul 2021 07:00

RNS Number : 4363F
DCC PLC
16 July 2021
Β 

Β 

16 July 2021

Β 

Board Changes

Β 

Β 

New Non-Executive Director

DCC plc, the leading international sales, marketing and support services group, announces the appointment of Ms. Laura Angelini as a non-executive Director and member of the Governance and Sustainability Committee with effect from the conclusion of the Company's AGM today.

Β 

Ms. Angelini is a highly experienced business leader with extensive knowledge of the healthcare sector. She has more than 25 years of experience in medical devices across multiple therapies and business models, including hospital products, consumer MedTech and home therapies. Ms. Angelini recently retired as General Manager of Baxter International's global Renal Care business, having joined Baxter in 2016 in this role. She previously held senior roles in Johnson & Johnson from 1991 to 2016.

Ms. Angelini has been a member of the Board of Trustees of Jacksonville University since 2018.

Β 

There are no details to be disclosed under Listing Rule 9.6.13 in respect of Ms. Angelini.

Β 

Following the appointment of Ms. Angelini, DCC will be fully compliant with the recommendations of the Hampton-Alexander and Parker Reviews on board diversity.

Β 

Appointment of Chairman

In accordance with the Company's Stock Exchange announcement of 18 May 2021, Mr. John Moloney will retire as a non-executive Director and Chairman of DCC at the conclusion of the Company's AGM today.

Mr. Mark Breuer, non-executive Director and Chairman Designate, will succeed Mr. Moloney as Chairman. Mr. Breuer will also become Chairman of the Governance and Sustainability Committee and will resign as a member of the Audit Committee.

Mark Breuer, Chairman Designate of DCC plc, said:

Β 

"I warmly welcome Laura Angelini to the Board. Her leadership experience, healthcare expertise and knowledge of the North American markets will enhance the Board's knowledge in key areas."

Β 

Β 

For reference:

Darragh Byrne

Company Secretary

Tel: +353 1 2799 400

Email: companysecretary@dcc.ie

Web: www.dcc.ie

Β 

Rossa White

Head of Group Investor Relations

Telephone: +353 1 2799 400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

Β 

Powerscourt (Media)

Lisa Kavanagh / Eavan Gannon

Telephone: +44 20 7250 1446

Email: DCC@powerscourt-group.com

Β 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2021, DCC generated revenue ofΒ Β£13.4 billionΒ and operating profit ofΒ Β£530.2 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOARAMMTMTBBTFB
Date   Source Headline
3rd Oct 20254:30 pmRNSHolding in Company TR-1
1st Oct 202512:43 pmRNSHolding in Company TR-1
25th Sep 20254:02 pmRNSHolding in Company TR-1
22nd Sep 20256:09 pmRNSHolding in Company TR-1
22nd Sep 202511:20 amRNSHolding in Company TR-1
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20257:00 amRNSDCC Healthcare sale completes and capital return
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:56 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20256:11 pmRNSHigh Court Approval of Reduction of Capital
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.